Insulin requirement profiles of short-term intensive insulin therapy in patients with newly diagnosed type 2 diabetes and its association with long-term glycemic remission

Diabetes Research and Clinical Practice
Liehua LiuYan-bing Li

Abstract

To investigate the insulin requirement profiles during short-term intensive continuous subcutaneous insulin infusion (CSII) in patients with newly diagnosed type 2 diabetes and its relationship with long-term glycemic remission. CSII was applied in 104 patients with newly diagnosed type 2 diabetes. Daily insulin doses were titrated and recorded to achieve and maintain euglycemia for 2 weeks. Measurements of blood glucose, lipid profiles as well as intravenous glucose tolerance tests were performed before and after the therapy. Afterwards, patients were followed up for 1 year. Total daily insulin dose (TDD) was 56.6±16.1IU at the first day when euglycemia was achieved (TDD-1). Thereafter, TDD progressively decreased at a rate of 1.4±1.0IU/day to 36.2±16.5IU at the end of the therapy. TDD-1 could be estimated with body weight, FPG, triglyceride and waist circumference in a multiple linear regression model. Decrement of TDD after euglycemia was achieved (ΔTDD) was associated with reduction of HOMA-IR (r=0.27, P=0.008) but not with improvement in β cell function. Patients in the lower tertile of ΔTDD had a significantly higher risk of hyperglycemia relapse than those in the upper tertile within 1 year (HR 3.4, 95%CI [1.4, 8.4], P=0...Continue Reading

References

Jan 28, 2006·The Diabetes Educator·Steven D Wittlin
Dec 6, 2006·The New England Journal of Medicine·Steven E KahnUNKNOWN ADOPT Study Group
Sep 12, 2008·The New England Journal of Medicine·Rury R HolmanH Andrew W Neil
Mar 2, 2011·Diabetes Technology & Therapeutics·Saptarshi BhattacharyaSadanand Dwivedi
Jan 26, 2012·Acta Diabetologica·Giuseppe PapaConcetta Finocchiaro
Sep 5, 2013·JAMA : the Journal of the American Medical Association·Yu XuUNKNOWN 2010 China Noncommunicable Disease Surveillance Group
Mar 14, 2014·The Lancet. Diabetes & Endocrinology·Caroline Kaercher KramerRavi Retnakaran

❮ Previous
Next ❯

Citations

May 18, 2016·Diabetes/metabolism Research and Reviews·Zohar LandauAvivit Cahn
Sep 25, 2018·Expert Opinion on Biological Therapy·Theocharis KoufakisKalliopi Kotsa
Jun 2, 2020·Journal of Diabetes Science and Technology·Guido FreckmannLutz Heinemann
Jun 6, 2020·The Cochrane Database of Systematic Reviews·Filip GnesinBianca Hemmingsen
Mar 24, 2016·Endocrine·Maria Ida MaiorinoDario Giugliano

❮ Previous
Next ❯

Related Concepts

Related Feeds

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.